Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-05
1988-07-19
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514249, 514318, 544350, 546194, 546203, 546204, A61K 31445, C07D21122, C07D21114
Patent
active
047585773
ABSTRACT:
Novel 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds are disclosed. The compounds have the property of inhibiting calcium induced contraction of the smooth muscle.
REFERENCES:
patent: 2985660 (1961-05-01), Judd et al.
patent: 3014911 (1961-12-01), Engelhardt
patent: 3476758 (1969-11-01), Fouche
patent: 3476761 (1969-11-01), Fouche
patent: 4356184 (1982-10-01), Deason et al.
Engelhardt, E. et al., J. Med. Chem. 8, pp. 829-835 (1965).
Merck Index, vol. 10, pp. 398-399 (1983).
Lowe, D. et al., Br. J. Pharmac., 74, pp. 651-663 (1981).
Young, S. et al., J. Org. Chem., 50, 399 (1985).
Merck & Co. , Inc.
Robertson Alice O.
Schwartz Richard A.
Sudol Michael C.
LandOfFree
4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for trea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for trea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for trea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597548